168 related articles for article (PubMed ID: 33961341)
1. Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations.
Newell LF; Dunlap J; Gatter K; Bagby GC; Press RD; Cook RJ; Fletcher L; Leonard JT; Leong KM; Bubalo JS; Olyaei A; Deloughery TG; Maziarz RT; Maynard E; Orloff SL; Enestvedt CK
Am J Transplant; 2021 Dec; 21(12):3894-3906. PubMed ID: 33961341
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal photopheresis: A case of graft-versus-host-disease and hemophagocytic lymphohistiocytosis following liver transplantation.
Xu Z; Otrock ZK
Transfusion; 2022 Nov; 62(11):2409-2413. PubMed ID: 36082758
[TBL] [Abstract][Full Text] [Related]
3. Hemophagocytic syndrome with graft-versus-host disease after liver transplantation: The bone marrow as a not so quiet battlefield?
Szabolcs P
Am J Transplant; 2021 Dec; 21(12):3823-3824. PubMed ID: 34453381
[No Abstract] [Full Text] [Related]
4. Graft-Versus-Host Disease Following Liver Transplantation: Development of a High-Incidence Rat Model and a Selective Prevention Method.
Yu E; Ueta H; Kimura H; Kitazawa Y; Sawanobori Y; Matsuno K
Am J Transplant; 2017 Apr; 17(4):979-991. PubMed ID: 27732765
[TBL] [Abstract][Full Text] [Related]
5. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.
Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for children with acute liver failure associated with secondary hemophagocytic lymphohistiocytosis.
Amir AZ; Ling SC; Naqvi A; Weitzman S; Fecteau A; Grant D; Ghanekar A; Cattral M; Nalli N; Cutz E; Kamath B; Jones N; De Angelis M; Ng V; Avitzur Y
Liver Transpl; 2016 Sep; 22(9):1245-53. PubMed ID: 27216884
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity and specificity of bone marrow hemophagocytosis in hemophagocytic lymphohistiocytosis.
Goel S; Polski JM; Imran H
Ann Clin Lab Sci; 2012; 42(1):21-5. PubMed ID: 22371906
[TBL] [Abstract][Full Text] [Related]
8. Cytosine-Phosphorothionate-Guanine Oligodeoxynucleotides Exacerbates Hemophagocytosis by Inducing Tumor Necrosis Factor-Alpha Production in Mice after Bone Marrow Transplantation.
Liu J; Guo YM; Onai N; Ohyagi H; Hirokawa M; Takahashi N; Tagawa H; Ubukawa K; Kobayashi I; Tezuka H; Minamiya Y; Ohteki T; Sawada K
Biol Blood Marrow Transplant; 2016 Apr; 22(4):627-636. PubMed ID: 26740374
[TBL] [Abstract][Full Text] [Related]
9. Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
Newell LF; Williams T; Liu J; Yu Y; Chen Y; Booth GC; Knight RJ; Goslee KR; Cook RJ; Leonard J; Meyers G; Traer E; Press RD; Fan G; Wang Y; Raess PW; Maziarz RT; Dunlap J
Transplant Cell Ther; 2021 Aug; 27(8):662.e1-662.e9. PubMed ID: 33901720
[TBL] [Abstract][Full Text] [Related]
10. An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.
Marsh RA; Kim MO; Liu C; Bellman D; Hart L; Grimley M; Kumar A; Jodele S; Myers KC; Chandra S; Leemhuis T; Mehta PA; Bleesing JJ; Davies SM; Jordan MB; Filipovich AH
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1625-31. PubMed ID: 24035782
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and predictors of post-transplant-associated hemophagocytic lymphohistiocytosis in adults.
Hattori N; Sato M; Uesugi Y; Nakata A; Sasaki Y; Shimada S; Watanuki M; Fujiwara S; Kawaguchi Y; Arai N; Uto Y; Matsui T; Yanagisawa K; Tahara S; Koeffler HP; Iezumi K; Nakamaki T
Int J Hematol; 2021 May; 113(5):693-702. PubMed ID: 33385294
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of Hemophagocytosis in Bone Marrow Aspirates: Experience from a Tertiary Care Hospital in North India.
Bhatti V; Kwatra KS; Kakkar N; John MJ
Int J Appl Basic Med Res; 2023; 13(3):153-158. PubMed ID: 38023600
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of hemophagocytic lymphohistiocytosis, HLH, with bone marrow transplantation].
Dürken M; Schneider EM; Blütters-Sawatzki R; Stollmann-Gibbels B; Nessler G; Bretz R; Körholz D; Probst EN; Holsten-Griffin H; Harps E; Zander AR; Janka GE
Klin Padiatr; 1998; 210(4):180-4. PubMed ID: 9743950
[TBL] [Abstract][Full Text] [Related]
14. Severe hematopoietic alterations in vitro, in bone marrow transplant recipients who develop graft-versus-host disease.
Martínez-Jaramillo G; Gómez-Morales E; Sánchez-Valle E; Mayani H
J Hematother Stem Cell Res; 2001 Jun; 10(3):347-54. PubMed ID: 11454310
[TBL] [Abstract][Full Text] [Related]
15. Reduced Intensity Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric Inherited Immune Deficiencies and Bone Marrow Failure Syndromes.
Klein OR; Bapty S; Lederman HM; Younger MEM; Zambidis ET; Jones RJ; Cooke KR; Symons HJ
J Clin Immunol; 2021 Feb; 41(2):414-426. PubMed ID: 33159275
[TBL] [Abstract][Full Text] [Related]
16. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.
Dey BR; McAfee S; Colby C; Sackstein R; Saidman S; Tarbell N; Sachs DH; Sykes M; Spitzer TR
Biol Blood Marrow Transplant; 2003 May; 9(5):320-9. PubMed ID: 12766882
[TBL] [Abstract][Full Text] [Related]
17. Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial.
Bolaños-Meade J; Cooke KR; Gamper CJ; Ali SA; Ambinder RF; Borrello IM; Fuchs EJ; Gladstone DE; Gocke CB; Huff CA; Luznik L; Swinnen LJ; Symons HJ; Terezakis SA; Wagner-Johnston N; Jones RJ; Brodsky RA
Lancet Haematol; 2019 Apr; 6(4):e183-e193. PubMed ID: 30878319
[TBL] [Abstract][Full Text] [Related]
18. Detecting Donor-Derived DNA by Real-Time PCR in Recipients Suspected of Graft-Versus-Host-Diseases After Liver Transplantation: A Case Series and Literature Review.
Ha C; Kim SJ; Kim JM; Joh JW; Jang KT; Choi GS; Kang ES
Ann Transplant; 2023 Feb; 28():e938287. PubMed ID: 36840341
[TBL] [Abstract][Full Text] [Related]
19. Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1.
Marsh RA; Bleesing JJ; Chandrakasan S; Jordan MB; Davies SM; Filipovich AH
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1641-5. PubMed ID: 24923536
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors of graft-versus-host disease after liver transplantation: A national study 2010-2020.
Huang Y; Wang Y; Chase RC; Yang L
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37756119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
